Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
4.790
-0.030 (-0.62%)
Dec 3, 2024, 12:14 PM EST - Market open
Aldeyra Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 11.74 | 13.34 | 15.37 | 11.28 | 9.99 | 12.15 | |
| Research & Development | 37.89 | 29.46 | 47.31 | 44.94 | 24.68 | 44.35 | |
| Operating Expenses | 49.64 | 42.79 | 62.68 | 56.22 | 34.67 | 56.51 | |
| Operating Income | -49.64 | -42.79 | -62.68 | -56.22 | -34.67 | -56.51 | |
| Interest Expense | -1.97 | -2.07 | -1.69 | -1.74 | -1.9 | -0.6 | |
| Interest & Investment Income | 6.81 | 7.32 | 2.35 | 0.19 | 0.29 | 1.54 | |
| EBT Excluding Unusual Items | -44.8 | -37.54 | -62.02 | -57.78 | -36.28 | -55.57 | |
| Pretax Income | -44.8 | -37.54 | -62.02 | -57.78 | -38.03 | -62.14 | |
| Income Tax Expense | - | - | - | - | -0.48 | -1.31 | |
| Net Income | -44.8 | -37.54 | -62.02 | -57.78 | -37.55 | -60.83 | |
| Net Income to Common | -44.8 | -37.54 | -62.02 | -57.78 | -37.55 | -60.83 | |
| Shares Outstanding (Basic) | 59 | 59 | 58 | 54 | 34 | 27 | |
| Shares Outstanding (Diluted) | 59 | 59 | 58 | 54 | 34 | 27 | |
| Shares Change (YoY) | 1.03% | 0.92% | 8.07% | 59.11% | 25.28% | 25.02% | |
| EPS (Basic) | -0.75 | -0.64 | -1.06 | -1.07 | -1.11 | -2.24 | |
| EPS (Diluted) | -0.75 | -0.64 | -1.06 | -1.07 | -1.11 | -2.24 | |
| Free Cash Flow | -30.67 | -30.33 | -56.65 | -42.56 | -37.49 | -44.99 | |
| Free Cash Flow Per Share | -0.52 | -0.51 | -0.97 | -0.79 | -1.10 | -1.66 | |
| EBITDA | -49.39 | -42.53 | -62.42 | -55.96 | -34.61 | -56.41 | |
| D&A For EBITDA | 0.25 | 0.26 | 0.26 | 0.26 | 0.06 | 0.1 | |
| EBIT | -49.64 | -42.79 | -62.68 | -56.22 | -34.67 | -56.51 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.